Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Senseonics Holdings, Inc. develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics is headquartered in Germantown, Maryland, and serves healthcare providers and patients through a network of distributors.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.9M | $13.7M | $16.4M | $22.4M | $22.5M | $35.3M |
| Gross profit | -$17.4M | -$800,000.00 | $2.7M | $3.1M | $533,000.00 | $15.8M |
| Operating income | -$79.1M | -$57.2M | -$68.6M | -$75.6M | -$74.8M | -$68.3M |
| Net income | -$175.2M | -$302.5M | $142.1M | -$60.4M | -$78.6M | -$69.1M |
| Diluted EPS | -$0.77 | -$0.72 | -$0.11 | -$0.11 | -$2.50 | -$1.66 |
| Operating cash flow | -$67.4M | -$56.1M | -$66.3M | -$70.2M | -$60.5M | -$59.1M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | -351.6% | -5.9% | 16.6% | 13.8% | 2.4% | 44.7% |
| Operating margin | -1598.9% | -418.1% | -418.7% | -337.7% | -333.0% | -193.8% |
| Net margin | -3539.5% | -2211.9% | 867.0% | -269.8% | -349.8% | -196.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9M | $4.3M | $8.3M | $6.3M | $6.6M | $8.1M | $14.3M | $11.7M |
| Gross profit | $298,000.00 | -$4.1M | $4.0M | $1.5M | $3.1M | $3.5M | $7.7M | $6.9M |
| Operating income | -$19.5M | -$22.8M | -$14.3M | -$13.5M | -$14.3M | -$19.6M | -$20.9M | -$31.8M |
| Net income | -$20.3M | -$24.0M | -$15.5M | -$14.3M | -$14.5M | -$19.5M | -$20.8M | -$32.3M |
| Diluted EPS | -$0.03 | -$0.77 | -$1.67 | -$0.40 | -$0.02 | -$0.43 | -$0.81 | -$0.71 |
| Operating cash flow | -$11.1M | -$14.8M | -$14.2M | -$16.1M | -$9.3M | -$15.8M | -$18.0M | -$32.0M |
| Free cash flow | — | — | — | -$16.5M | — | — | — | -$32.1M |
| Gross margin | 6.1% | -95.0% | 47.6% | 24.1% | 46.9% | 42.8% | 53.8% | 59.3% |
| Operating margin | -400.7% | -535.9% | -172.0% | -215.6% | -215.4% | -242.1% | -146.8% | -271.9% |
| Net margin | -417.0% | -562.4% | -186.3% | -227.9% | -218.1% | -241.3% | -146.0% | -276.1% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | ROEDER DOUGLAS A | Award | 2,751 | $5.36 | $14,745.36 | filing |
| 2026-07-01 | Fiorentino Edward | Award | 2,635 | $5.36 | $14,123.60 | filing |
| 2026-07-01 | Steven Edelman | Award | 2,402 | $5.36 | $12,874.72 | filing |
| 2026-07-01 | Prince Douglas S | Award | 1,515 | $5.36 | $8,120.40 | filing |
| 2026-06-15 | Goodnow Timothy T· President and CEO | Tax withholding | 32,598 | $7.18 | $234,053.64 | filing |
| 2026-06-15 | JAIN Mukul· Chief Operating Officer | Tax withholding | 16,194 | $7.18 | $116,272.92 | filing |
| 2026-06-15 | Horton Kenneth L· GC & Corp. Development Advisor | Tax withholding | 9,545 | $7.18 | $68,533.10 | filing |
| 2026-06-15 | HANSEN BRIAN B· Chief Commercial Officer | Tax withholding | 5,420 | $7.18 | $38,915.60 | filing |
| 2026-06-15 | Sullivan Frederick T.· Chief Financial Officer | Tax withholding | 5,397 | $7.18 | $38,750.46 | filing |
| 2026-06-15 | Kaufman Francine· Chief Medical Officer | Tax withholding | 4,010 | $7.18 | $28,791.80 | filing |
| 2026-05-20 | Larkin Sharon | Award | 9,852 | $0.00 | $0.00 | filing |
| 2026-05-20 | DeFalco Stephen P | Award | 9,852 | $0.00 | $0.00 | filing |
| 2026-05-20 | Steven Edelman | Award | 9,852 | $0.00 | $0.00 | filing |
| 2026-05-20 | Fiorentino Edward | Award | 9,852 | $0.00 | $0.00 | filing |
| 2026-05-20 | Prince Douglas S | Award | 9,852 | $0.00 | $0.00 | filing |
| 2026-05-20 | ROEDER DOUGLAS A | Award | 9,852 | $0.00 | $0.00 | filing |
| 2026-05-19 | Kaufman Francine· Chief Medical Officer | Award | 63,177 | $0.00 | $0.00 | filing |
| 2026-05-19 | Horton Kenneth L· GC & Corp. Development Advisor | Award | 157,943 | $0.00 | $0.00 | filing |
| 2026-05-19 | JAIN Mukul· Chief Operating Officer | Award | 270,759 | $0.00 | $0.00 | filing |
| 2026-05-19 | Sullivan Frederick T.· Chief Financial Officer | Award | 90,253 | $0.00 | $0.00 | filing |
| 2026-05-19 | HANSEN BRIAN B· Chief Commercial Officer | Award | 90,253 | $0.00 | $0.00 | filing |
| 2026-05-19 | Goodnow Timothy T· President and CEO | Award | 553,701 | $0.00 | $0.00 | filing |
| 2026-05-15 | Goodnow Timothy T· President and CEO | Tax withholding | 28,598 | $5.82 | $166,440.36 | filing |
| 2026-05-15 | JAIN Mukul· Chief Operating Officer | Tax withholding | 13,681 | $5.82 | $79,623.42 | filing |
| 2026-05-15 | Sullivan Frederick T.· Chief Financial Officer | Tax withholding | 9,005 | $5.82 | $52,409.10 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.